Literature DB >> 2429229

Neurokinin A and substance P in striato-nigral neurons in rat brain.

N Lindefors, E Brodin, U Ungerstedt.   

Abstract

The effect of an ibotenic acid lesion in rostral striatum on tissue levels of neurokinin A and substance P in striatum and substantia nigra was studied in rat brain. A total of 32 micrograms (10 mg/ml) ibotenic acid was injected in four positions to lesion striatal cell bodies rostral to bregma. The neurokinin A level was reduced to a third of the control value in striatum and to less than half of the control level in substantia nigra. Neurokinin A, in addition to substance P, is shown to be possibly present in striato-nigral neurons, which provides further evidence for the existence of a striato-nigral tachykinin pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429229     DOI: 10.1016/0143-4179(86)90039-9

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  4 in total

1.  Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons.

Authors:  J Alberch; E Arenas; E Pérez-Navarro; J Marsal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

2.  Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.

Authors:  N Lindefors; E Brodin; U Tossman; J Segovia; U Ungerstedt
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

3.  Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen.

Authors:  S Brené; N Lindefors; M Herrera-Marschitz; H Persson
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

4.  Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.

Authors:  M S Reid; M Herrera-Marschitz; T Hökfelt; N Lindefors; H Persson; U Ungerstedt
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.